
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
| Review | Status | Reviewer | Date | Notes |
|---|---|---|---|---|
| schema validation | not_started | Run scripts/build.ps1 -Conformance. | ||
| clinical review | not_started | Awaiting clinician review; check the DSM-5-TR criteria counts (tolerance and withdrawal counted because use was not as prescribed), the MME totals, the one-week delay before buprenorphine at his choice with naloxone and seven-day supplies in between, the in-office induction, buprenorphine with a benzodiazepine, the alprazolam to diazepam conversion and the taper pace, amlodipine with valsartan as a single pill for stage 2 hypertension, tirzepatide for obesity with obstructive sleep apnea while on buprenorphine, in-laboratory polysomnography on opioids, stopping phentermine for glaucoma and blood pressure, and acute back pain treated by splitting the buprenorphine dose with naproxen. | ||
| provenance review | not_started | Sources: The New York Times obituary (1977), Graceland's official timeline, four UPI wire reports of the 1981 trial, the 1977 Rolling Stone report, a HISTORY article (2026), and the PubMed abstract of Zegers et al. (2025). The Commercial Appeal could not be reached and the biographies were not read. The cause of death is graded R and disputed; the steroid explanation of his glaucoma is R, probable; the megacolon account is R, possible. | ||
| safe messaging review | not_started | Drug and mental-health claims are marked sensitive; the 1973 hospital stay and the trial testimony are recorded without detail beyond the reports; his death is recorded in one plain sentence and its disputed cause separately; person-first language; weight is described without stigma; the safety assessment gives the 988 Suicide & Crisis Lifeline and addresses means safety, including firearms. His physician appears only in documented history, with no modern decision or statement attributed to him; no living person is named, and nothing is attributed to his former wife or his daughter. |
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|---|---|---|
| 2026-08-07 Progress note 03 (C-CDA) | Urine drug test, including buprenorphine metabolite and fentanyl | At the start of treatment, then about monthly while doses are changing | Not collected: he left for a rehearsal before giving a sample. No harm is evident: the monitoring program shows only this clinic's prescriptions and he reports no other use. Corrective action: sample to be collected at the start of the next visit |
| 2026-09-23 Progress note 06 (C-CDA) | Weekly video visits while away | Weekly during engagements and tours | The second weekly video visit in Las Vegas was missed when a rehearsal ran late; a nurse reached him by phone the next day and found him well. No harm resulted. Corrective action: a fixed weekly time on tour with a backup slot the same day |
| Visit | Type | Item | Status | Detail |
|---|---|---|---|---|
| 2026-08-14 Progress note 04 (C-CDA) | Prevention | HIV screening | Ordered | Once for all adults; drawn today with his agreement |
| 2026-08-14 Progress note 04 (C-CDA) | Prevention | Hepatitis C screening | Ordered | Once for all adults; drawn today |
| 2026-08-14 Progress note 04 (C-CDA) | Prevention | Hepatitis B screening | Ordered | Triple panel once for all adults; drawn today |
| Claim | Statement | Certainty |
|---|---|---|
| CLM-0008 | A 2025 ophthalmology review interprets his glaucoma as steroid-induced, from lifelong use of steroids both prescribed and self-administered, with secondary angle closure most likely due to anterior uveitis. | probable |
| CLM-0013 | The cause of his death is disputed. The medical examiner gave cardiac arrhythmia, citing a history of mild hypertension and evidence of coronary artery disease, and later ruled it heart disease; the autopsy report was never released. Trial testimony said that 14 drugs, including codeine at ten times the maximum accepted level, were found in tissue samples, and later accounts attribute the death to multiple prescription drugs, to heart disease, or to straining with a severely enlarged colon. | disputed |
| CLM-0014 | His physician later said that he had a severe form of megacolon, his colon about twice its normal diameter and impacted with stool at his death. | possible |
| Claim | Grade | Statement |
|---|---|---|
| CLM-0003 | D | From October 15 to November 1, 1973, he was treated at Baptist Memorial Hospital in Memphis under an assumed name; at the 1981 trial of his physician, an internal medicine specialist who reviewed the records testified that the consulting physicians were "withdrawing him from narcotic drugs." |
| CLM-0004 | D | He was treated at Baptist Hospital again from January 28 to February 13, 1975, when the admission note recorded abdominal problems and swelling of the face, hands and legs, and from August 21 to September 25, 1975, for shortness of breath and swelling. In 1977 the medical examiner said that the drugs he found were those prescribed for hypertension and a blockage of the colon, for which Presley had been hospitalized twice in 1975. |
| CLM-0005 | D | In 1977 an unnamed Baptist Hospital employee told Rolling Stone that he had been treated there for "hypertension, enlarged colon, gastroenteritis, stomach inflammation," had "a severe liver condition," had received cortisone, and weighed at least 230 pounds; the hospital's doctors discounted a suggestion of lupus. |
| CLM-0008 | R | A 2025 ophthalmology review interprets his glaucoma as steroid-induced, from lifelong use of steroids both prescribed and self-administered, with secondary angle closure most likely due to anterior uveitis. |
| CLM-0009 | D | At the 1981 trial of his physician, George Nichopoulos, prosecutors showed that the physician had prescribed about 19,000 doses of stimulants, sedatives and painkillers for him in the last 30 months of his life, including 1,679 addictive pills in 205 days between the two 1975 hospital stays; the defense argued that he obtained drugs from many other sources, including amphetamines mailed from the West Coast, and a detective testified to collecting prescriptions from 140 Memphis pharmacies. |
| CLM-0010 | D | Testimony at the trial described him as addicted to prescribed stimulants, sedatives and painkillers; the internal medicine specialist testified, "Absolutely. He was addicted." On November 4, 1981, the jury acquitted the physician of overprescribing, citing his efforts to substitute placebos and intercept drugs sent from elsewhere; the physician then said that drugs "may have played a part" in the death. |
| CLM-0011 | D | It was believed that he neither smoked nor drank alcohol. |
| CLM-0013 | R | The cause of his death is disputed. The medical examiner gave cardiac arrhythmia, citing a history of mild hypertension and evidence of coronary artery disease, and later ruled it heart disease; the autopsy report was never released. Trial testimony said that 14 drugs, including codeine at ten times the maximum accepted level, were found in tissue samples, and later accounts attribute the death to multiple prescription drugs, to heart disease, or to straining with a severely enlarged colon. |
None.
Every note in the record, with its type. All clinical content is synthetic.
| Date | Result | Value | Flag |
|---|---|---|---|
| 2026-07-10 | Glucose | 104 mg/dL (high) | High |
| 2026-07-10 | Hemoglobin A1c | 5.8% (high) | High |
| 2026-07-10 | ALT | 72 U/L (high) | High |
| 2026-07-10 | AST | 52 U/L (high) | High |
| 2026-07-10 | GGT | 78 U/L (high) | High |
| 2026-08-14 | Total cholesterol | 214 mg/dL (high) | High |
| 2026-08-14 | HDL cholesterol | 38 mg/dL (low) | Low |
| 2026-08-14 | LDL cholesterol (calculated) | 140 mg/dL (high) | High |
| 2026-08-14 | Triglycerides | 180 mg/dL (high) | High |